Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Margaret Moffatt"'
Autor:
Sarah Pugh, Matt Wasserman, Margaret Moffatt, Susana Marques, Juan Manuel Reyes, Victor A. Prieto, Davy Reijnders, Mark H. Rozenbaum, Juha Laine, Heidi Åhman, Raymond Farkouh
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 2, Pp 305-324 (2020)
Abstract Introduction Widespread use of ten-valent (Synflorix™, GSK) or 13-valent (Prevenar 13™; Pfizer) conjugate vaccination programs has effectively reduced invasive pneumococcal disease (IPD) globally. However, IPD caused by serotypes not con
Externí odkaz:
https://doaj.org/article/e0bd0f8cea3d44338a870cad37762551
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 1, Pp 71-78 (2018)
Introduction: Pneumococcal conjugate vaccines (PCVs) have provided a significant clinical and economic impact globally. The majority of countries which have implemented an infant PCV program have observed a substantial reduction in the burden of inva
Externí odkaz:
https://doaj.org/article/dc9a23550ced4f23988b2100ab499af6
Autor:
VA Prieto, Juha Laine, Mark H. Rozenbaum, Matt Wasserman, Heidi Åhman, Davy Reijnders, Sarah J. Pugh, Margaret Moffatt, Susana Castro Marques, J. Reyes, Raymond Farkouh
Publikováno v:
Infectious Diseases and Therapy
Infectious Diseases and Therapy, Vol 9, Iss 2, Pp 305-324 (2020)
Infectious Diseases and Therapy, Vol 9, Iss 2, Pp 305-324 (2020)
Introduction Widespread use of ten-valent (Synflorix™, GSK) or 13-valent (Prevenar 13™; Pfizer) conjugate vaccination programs has effectively reduced invasive pneumococcal disease (IPD) globally. However, IPD caused by serotypes not contained wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00d4fcd2d04054bf3d6cf5bf69c62fd0
https://doi.org/10.1007/s40121-020-00287-5
https://doi.org/10.1007/s40121-020-00287-5
Autor:
Margaret Moffatt, Germano Ferreira, Luis Jodar, Cassandra Hall-Murray, Bradford D Gessner, Thomas Verstraeten, Heinz-Josef Schmitt, Anita H J van den Biggelaar, Myint Tin Tin Htar, Heather L Sings
Publikováno v:
Expert Review of Vaccines. 18:1069-1089
Introduction: The introduction of 7-valent pneumococcal conjugate vaccine (PCV7) in childhood immunization programs reduced antimicrobial-resistant pneumococcal infections by vaccine serotypes. However, emerging antimicrobial-resistant non-vaccine se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18b45fd55f52267ba91d1de3ca724162
https://doi.org/10.1080/14760584.2019.1676155
https://doi.org/10.1080/14760584.2019.1676155
Autor:
Sophie Hill, Matt Wasserman, L. Ruff, Margaret Moffatt, Kateryna Onishchenko, Christopher U. Jones, Sarah J. Pugh
Publikováno v:
Human Vaccines & Immunotherapeutics
Although a proven and effective preventive health measure, childhood immunization programs remain vulnerable to budgetary pressures. Sustainable financing of immunization programs is an important issue that presents a challenge for middle-income coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e23264191d78da722cafbdfaf755f3
https://pubmed.ncbi.nlm.nih.gov/30843757
https://pubmed.ncbi.nlm.nih.gov/30843757
Autor:
Joel Bobula, Andrew G. Bushmakin, Maya Kumar, Marco DiBonaventura, Xuemei Luo, Margaret Moffatt
Publikováno v:
Journal of Women's Health. 24:713-722
Vulvovaginal atrophy (VVA) is a condition associated with decreased estrogenization of the vaginal tissue, which can result in vaginal dryness, irritation, and dyspareunia. This study quantified the burden associated with VVA symptoms across the Unit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::490f4e4bb50271767591c464ec7217cb
https://doi.org/10.1089/jwh.2014.5177
https://doi.org/10.1089/jwh.2014.5177
Publikováno v:
Expert review of vaccines. 17(1)
Pneumococcal conjugate vaccines (PCVs) have provided a significant clinical and economic impact globally. The majority of countries which have implemented an infant PCV program have observed a substantial reduction in the burden of invasive pneumococ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691419b8c7ddff55c94cd84a695ed407
https://pubmed.ncbi.nlm.nih.gov/29164952
https://pubmed.ncbi.nlm.nih.gov/29164952
Autor:
Annlouise R, Assaf, Andrew G, Bushmakin, Nina, Joyce, Michael J, Louie, Michael, Flores, Margaret, Moffatt
Publikováno v:
American healthdrug benefits. 10(6)
The direct costs associated with menopausal and postmenopausal symptoms (hereafter "menopausal symptoms") may include the costs of physician and emergency department visits, medications, laboratory testing, and the management of side effects. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::639a5a468f64f251dcf6870e9769a348
https://pubmed.ncbi.nlm.nih.gov/28975014
https://pubmed.ncbi.nlm.nih.gov/28975014